For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year, an…

City Journal
End Covid Now
More than 22 million doses of Covid-19 vaccine have been distributed in the United States so far, yet only 6.7…

National Review
Why Are We Vaccinating People Who Have Recovered from COVID-19?
Now that Pfizer and Moderna have received emergency-use authorizations for their COVID-19 vaccines, the tough work of deciding how to allocate the limited supply of doses…
Search Posts
Citation
Trouble Standards
Op-Eds
Auto Fuel Economy Standards: Good For The Environment? Or A Cause Of Highway Deaths?
Full Policy Brief Available in PDF Format Executive Summary The Corporate Average Fuel Economy Program was part of legislation…
Op-Eds
The Liberating Benefits Of Automobility
Full Article Available in PDF Format American’s love affair with the automobile has become…
Op-Eds
Biotechnology Flirts with the Regulators
Biotechnology, like other unfamiliar high tech industries, offers great hopes but arouses even greater fears. Politicians, the record proves, are far more likely to respond to…
News Release
AIDS Protest at FDA: The Issue Is Freedom
The Competitive Enterprise Institute, a Washington-based free market advocacy group, today expressed its support for the AIDS protest at the Food & Drug Administration…
Citation